1. COVID-19 vaccine safety monitoring

   News item 27 February 2021 Pages: 1 - 1

2. Medicines in Pregnancy Registry shows reduced valproate use

   News item 27 February 2021 Pages: 2 - 2

3. Meeting highlights from PRAC: February 2021

   News item 27 February 2021 Pages: 3 - 3

4. Signal for dronedarone-induced hyperkalaemia

   News item 27 February 2021 Pages: 4 - 4

5. Tozinameran vaccination in Canada: no change in benefit-risk profile

   News item 27 February 2021 Pages: 5 - 5

6. Warning of risks of unauthorised products from Galena Pharm

   News item 27 February 2021 Pages: 6 - 6

7. ISMP releases Top 10 list of medication errors and hazards in 2020

   News item 27 February 2021 Pages: 7 - 7

8. COVID-10 vaccine safety monitoring in US: no serious concerns

   Clinical study 27 February 2021 Pages: 8 - 8

9. Liver disease: ulipristal acetate vs GnRH agonists

   Clinical study 27 February 2021 Pages: 9 - 9

10. Proton pump inhibitors in children: increased risk of asthma

    Clinical study 27 February 2021 Pages: 10 - 10

11. Rituximab adverse events in younger patients

    Clinical study 27 February 2021 Pages: 11 - 11

12. Social media data for adverse drug reaction reporting?

    Clinical study 27 February 2021 Pages: 12 - 12

13. Steroid-related complications in GVHD incur substantial costs

    Clinical study 27 February 2021 Pages: 13 - 13

14. Other adverse reaction research

    News item 27 February 2021 Pages: 14 - 14

15. Acarbose

    Case report 27 February 2021 Pages: 15 - 15

16. Acenocoumarol

    Case report 27 February 2021 Pages: 16 - 16

17. Adalimumab

    Case report 27 February 2021 Pages: 17 - 17

18. Adalimumab

    Case report 27 February 2021 Pages: 18 - 18

19. Adalimumab/etanercept

    Case report 27 February 2021 Pages: 19 - 19

20. Adalimumab/methotrexate

    Case report 27 February 2021 Pages: 20 - 20

21. Adenosine/digoxin

    Case report 27 February 2021 Pages: 21 - 21

22. Albumin human/midodrine/octreotide

    Case report 27 February 2021 Pages: 22 - 22

23. Alectinib

    Case report 27 February 2021 Pages: 23 - 23

24. Alizapride

    Case report 27 February 2021 Pages: 24 - 24

25. Allopurinol/azathioprine interaction

    Case report 27 February 2021 Pages: 25 - 25

26. Alprazolam/clonazepam/fentanyl

    Case report 27 February 2021 Pages: 26 - 26

27. Aluminium hydroxide/magnesium hydroxide/magnesium citrate

    Case report 27 February 2021 Pages: 27 - 27

28. Amfetamine/dexamfetamine

    Case report 27 February 2021 Pages: 28 - 28

29. Amikacin

    Case report 27 February 2021 Pages: 29 - 29

30. Aminocaproic-acid/protamine-sulfate

    Case report 27 February 2021 Pages: 30 - 30

31. Amiodarone

    Case report 27 February 2021 Pages: 31 - 31

32. Amisulpride/dipotassium-clorazepate/haloperidol

    Case report 27 February 2021 Pages: 32 - 32

33. Amitriptyline overdose

    Case report 27 February 2021 Pages: 33 - 33

34. Amoxicillin/clavulanic acid

    Case report 27 February 2021 Pages: 34 - 34

35. Amoxicillin/phenoxymethylpenicillin

    Case report 27 February 2021 Pages: 35 - 35

36. Amphotericin-b

    Case report 27 February 2021 Pages: 36 - 36

37. Amphotericin-B-liposomal

    Case report 27 February 2021 Pages: 37 - 37

38. Ampicillin/gentamicin

    Case report 27 February 2021 Pages: 38 - 38

39. Anakinra

    Case report 27 February 2021 Pages: 39 - 39

40. Anticoagulants

    Case report 27 February 2021 Pages: 40 - 40

41. Anticoagulants

    Case report 27 February 2021 Pages: 41 - 41

42. Antiepileptic drugs

    Case report 27 February 2021 Pages: 42 - 42

43. Antifungals

    Case report 27 February 2021 Pages: 43 - 43

44. Antineoplastics

    Case report 27 February 2021 Pages: 44 - 44

45. Antineoplastics

    Case report 27 February 2021 Pages: 45 - 45

46. Antineoplastics

    Case report 27 February 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 27 February 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 27 February 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 27 February 2021 Pages: 49 - 49

50. Antineoplastics/antithrombotics interaction

    Case report 27 February 2021 Pages: 50 - 50